Balanced news tone
News Sentiment
NYXH sentiment intelligence
Nyxoah news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-0.6% over one week, +23.0% over four weeks, trend inactive, and below fair value.
Price to sales forward of Nyxoah SA – SWB:5YI
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to sales forward of Nyxoah SA – SWB:5YI
This article provides a brief financial overview for Nyxoah SA (SWB:5YI), focusing on its forward price-to-sales ratio. It indicates that no trades have occurred and presents links to various financial data, news, and community sections for the company on the TradingView platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 01:40
- Source
- TradingView
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 23:02
- Source
- MarketBeat
Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement
Nyxoah (NASDAQ: NYXH) announced strong preliminary Q2 2026 results, with global net revenue expected to be €7.7 million and U.S. revenue €5.2 million, both demonstrating over 20% sequential growth. The company also secured $110 million in financing and anticipates a significant i
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:11
- Source
- Stock Titan
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target
Stifel has reiterated its Hold rating on Nyxoah SA stock, maintaining a $3.00 price target after the company's Investor Day. The firm expressed caution regarding Nyxoah's ambitious breakeven revenue and gross margin targets, noting that the company operates in a small market shar
- Tone
- Negative 37/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:11
- Source
- Investing.com
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com
Stifel maintained its Hold rating and $3.00 price target for Nyxoah SA (NASDAQ:NYXH) following the company's Investor Day. The firm expressed a cautious outlook, citing limited new information, ambitious breakeven and gross margin targets, and the company's projected need for add
- Tone
- Negative 36/100
- Event
- Analyst action
- Published
- 09 Jul 2026 19:40
- Source
- Investing.com Nigeria
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85
Baird has reiterated its Hold rating on Nyxoah SA (NYXH.US) but has reduced its target price for the company's shares to $2.85. This adjustment reflects Baird's updated outlook on Nyxoah SA's financial prospects and market valuation.
- Tone
- Negative 31/100
- Event
- Analyst action
- Published
- 09 Jul 2026 19:40
- Source
- Moomoo
Price to earnings forward of Nyxoah SA – SWB:5YI
This article provides a brief financial overview of Nyxoah SA (SWB:5YI), focusing on its forward price-to-earnings ratio. The content indicates the market was closed with no trades at the time of viewing. It also lists various data providers for market and reference information.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 18:11
- Source
- TradingView
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Nyxoah announced preliminary unaudited second-quarter 2026 financial results, reporting an expected global net revenue of €7.7 million, driven by strong U.S. launch momentum. The company saw significant growth in U.S. net revenue and commercial indicators, including increased sur
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 08 Jul 2026 19:40
- Source
- GlobeNewswire
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution
Nyxoah's analyst update has reduced its fair value estimate by approximately 21%, from €7.37 to €5.80, following a recent capital raise and analyst caution. While Piper Sandler remains optimistic about the Genio product's uptake and maintains an "Overweight" rating, Stifel has lo
- Tone
- Negative 36/100
- Event
- Analyst action
- Published
- 08 Jul 2026 09:11
- Source
- Market source
Nyxoah (NYXH) Reports Strong Momentum and Financial Progress in Q2
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 02:48
- Source
- GuruFocus
Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed
Nyxoah reported preliminary second-quarter revenue of €1.7 million, an increase from €1.3 million in the first quarter of 2026, driven by growth in Germany. The company reaffirmed its 2026 outlook, expecting revenue between €9 million and €12 million and maintaining its gross mar
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 07 Jul 2026 21:10
- Source
- Moomoo
Nyxoah reports Q2 2026 preliminary revenue of €7.7M
Nyxoah reported preliminary revenue of €7.7 million for the second quarter of 2026. This financial update provides an early look at the company's performance during the last quarter.
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 07 Jul 2026 21:10
- Source
- MSN
Nyxoah says U.S. launch lifted Q2 revenue 21% sequentially
Nyxoah (Nasdaq:NYXH) announced preliminary, unaudited Q2 2026 results including global net revenue of €7.7 million, a 21% sequential increase, driven by U.S. revenue of €5.2 million, up 22%. The company reaffirmed its full-year 2026 revenue guidance of €36–40 million and detailed
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 07 Jul 2026 20:10
- Source
- Stock Titan
NYXH - Nyxoah SA Latest SEC Filings
This article provides the latest SEC filing information for Nyxoah SA (NYXH), including its current stock performance, key financial metrics, and various valuation ratios. The data covers market capitalization, sales, earnings per share (EPS) figures, insider and institutional ow
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 04 Jul 2026 18:10
- Source
- Finviz
ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Nyxoah adds 146,531 shares as voting rights reach 100.1 million
Nyxoah (Nasdaq: NYXH) has updated its share capital and voting rights as of June 30, 2026, following the issuance of 146,531 new shares from exercised restricted share units. The company's share capital is now EUR 7,075,152.31, with 100,072,815 ordinary shares and an equal number
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 01 Jul 2026 04:10
- Source
- Stock Titan
Information on the total number of voting rights and shares
Nyxoah SA has released updated information on its total number of voting rights and shares as of June 30, 2026. This follows the issuance of 146,531 new shares due to the exercise of restricted share units. The company reported a total of 100,072,815 voting rights and shares, alo
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 16:30
- Source
- GlobeNewswire
Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%.
Nyxoah SA announced that Orin Hirchman, through controlled entities, has acquired 14.55% of voting rights as of June 10, 2026, exceeding the 10% disclosure threshold. Concurrently, Resmed Inc. reduced its stake to 1.95%, falling below the 3% threshold. These shifts in significant
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Jun 2026 20:40
- Source
- Pluang
Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95%
Nyxoah (NASDAQ: NYXH) has announced two significant transparency notifications concerning major shareholdings, dated June 10, 2026. Entities controlled by Orin Hirchman, through AIGH Investment Partners, LP and WVP Emerging Manager Onshore Fund LLC - AIGH Series, now collectively
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 29 Jun 2026 20:40
- Source
- Stock Titan
Publication relating to transparency notifications
Nyxoah SA announced that it received two transparency notifications regarding changes in shareholdings. Orin Hirchman's controlled entities acquired voting securities, crossing the 10% threshold to hold 14.55% of shares as of June 10, 2026. Separately, Resmed Inc. reported a pass
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 20:40
- Source
- GlobeNewswire
Price to earnings forward of Nyxoah SA – LSX:A2QCWK
This article presents financial information for Nyxoah SA (LSX:A2QCWK), specifically its forward price-to-earnings ratio. The content primarily consists of navigation and boilerplate text from TradingView, with a placeholder for the actual "Period Value Change" data. The financia
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Jun 2026 08:40
- Source
- TradingView
NYXH Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Nyxoah SA (NYXH) stock, gathering analysts' opinions on its future price, with a max estimate of 11.10 EUR and a min estimate of 2.58 EUR. It also details the company's recent financial performance, including earnings, revenue
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 14:40
- Source
- TradingView
Nyxoah to Host Investor Day in New York on July 8, 2026
Nyxoah SA, a medical technology company specializing in Obstructive Sleep Apnea (OSA) solutions, announced it will host an Investor and Analyst Day in New York on Wednesday, July 8, 2026. The event will take place at Bank of America's offices from 10:00 AM to 12:30 PM ET and will
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 25 Jun 2026 03:40
- Source
- Sahm
Form 6K Nyxoah For: 23 June By Investing.com
This article announces the filing of Form 6K by Nyxoah on June 23, 2026. It appears to be a standard financial reporting notification from Investing.com, providing basic details without further commentary or analysis within the snippet provided.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 13:39
- Source
- Investing.com Nigeria
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns
Nyxoah (ENXTBR:NYXH) has seen its fair value estimate drop by 18% to €7.37 per share, following analyst cuts influenced by concerns about capital needs and execution risk. While some analysts like Piper Sandler remain optimistic about the Genio launch and revenue trends, others l
- Tone
- Negative 29/100
- Event
- Earnings
- Published
- 24 Jun 2026 12:30
- Source
- Market source
Nyxoah lines up U.S. launch update, reimbursement talk for July 8
Nyxoah (NYXH) will host an Investor and Analyst Day in New York on July 8, 2026, to discuss the U.S. Genio launch momentum, OSA market dynamics, reimbursement strategies, and the company’s path to profitability. The event, held at Bank of America Tower, will feature Nyxoah's lead
- Tone
- Positive 71/100
- Event
- Analyst action
- Published
- 23 Jun 2026 19:40
- Source
- Stock Titan
Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders
Nyxoah (NASDAQ: NYXH) has secured a $15 million loan tranche from the European Investment Bank, bringing its total new capital raised in June 2026 to approximately $110 million. This non-dilutive debt will fund the U.S. commercial launch of its Genio sleep apnea system, alongside
- Tone
- Positive 70/100
- Event
- Balance sheet
- Published
- 23 Jun 2026 19:40
- Source
- Stock Titan
Form 13G NYXOAH SA For: 22 June By Investing.com
This article reports on a Form 13G filing for NYXOAH SA on June 22. It is a brief announcement from Investing.com with no further details. The content primarily includes disclaimers about the risks of trading financial instruments and cryptocurrencies.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 16:39
- Source
- Investing.com Australia
AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH)
AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman have jointly reported a 14.5% stake in NYXOAH (NASDAQ: NYXH), amounting to 14,534,880 shares of Common Stock. This Schedule 13G filing indicates that the reporting persons hold sole voting and dispositi
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 10:12
- Source
- Stock Titan
Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary
Nyxoah (NYXH) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting the significant market opportunity in obstructive sleep apnea (OSA) and the differentiating features of its Genio system. The company discussed its successful U.S. launch post-FDA approval,
- Tone
- Positive 71/100
- Event
- Regulatory and legal
- Published
- 21 Jun 2026 12:12
- Source
- Quartr